Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder that affects various organs and systems. Increased apoptosis, together with defects in the uptake of apoptotic bodies, are thought to have a pathogenic role in SLE. By detection of chromatin condensation, 30% of apoptosis was detected in peripheral blood mononuclear cells (PBMC) from Thai patients with active SLE. Therefore, understanding of the molecular processes in PBMC apoptosis may allow us to gain insight into pathophysiology of SLE. Thus, genes involved in the apoptosis of PBMC from these patients were investigated ex vivo by cDNA array analysis. Seventeen apoptosis-related genes were stimulated in active SLE, more than twofold higher than in inactive SLE. These genes are classified into six groups, namely death receptors, death ligands, caspases, bcl-family, and neutral proteases and genes involved in endoplasmic reticulum stress-mediated apoptosis, such as caspase-4 and GADD153. Among those stimulated genes, tumor necrosis factor (TNF) and the TNF-receptor family were drastically up-regulated 60- and 19-fold higher than in healthy controls, respectively. Moreover, the degree of apoptosis correlated with the level of TNF-α in plasma, suggesting that the TNF family plays a role in the induction of apoptosis in SLE. To verify this hypothesis, PBMC from healthy individuals were treated with plasma from active SLE patients in the presence or absence of etanercept, a TNF inhibitor. In the presence of etanercept, active SLE plasma reduced the level of apoptosis to 26.43%. In conclusion, massive apoptotic death of PBMC occurred during the active stage of SLE. The molecular pathway of SLE-PBMC apoptosis was mediated at least via TNF/TNFR signaling pathway, which was confirmed by functional test of TNF-α in SLE patients’ plasma.
Similar content being viewed by others
References
Manson JJ, Isenberg DA (2003) The pathogenesis of systemic lupus erythematosus. Neth J Med 61:343–346
Hanhn B (2001) Systemic lupus erythematosus. In Brewnwald E (ed) Principles of internal medicine. McGraw-Hill, New York pp 1922–1928
Gordon C, Salmon M (2001) Update on systemic lupus erythematosus: autoantibodies and apoptosis. Clin Med 1:10–14
Jin O, Sun LY, Zhou KX, Zhang XS, Feng XB, Mok MY et al (2005) Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin Rheumatol 24:107–110
Bijl M, Limburg PC, Kallenberg CG, Borchers A, Ansari AA, Hsu T et al (2001) New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. Neth J Med 59:66–75
Devitt A, Pierce S, Oldreive C, Shingler WH, Gregory CD (2003) CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Cell Death Differ 10:371–382
Steinbach F, Henke F, Krause B, Thiele B, Burmester GR, Hiepe F (2000) Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 59:283–288
Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265–285
Gabler C, Kalden JR, Lorenz HM (2003) The putative role of apoptosis-modified histones for the induction of autoimmunity in systemic lupus erythematosus. Biochem Pharmacol 66:1441–1446
Shono M, Shimizu I, Omoya T, Hiasa A, Honda H, Tomita Y et al (1998) Differences in ethidium bromide and 4’-6-diamidino-2-phenylindole staining profiles with regard to DNA fragmentation during apoptosis. Biochem Mol Biol Int 46:1055–1061
Theerasurakarn S, Ubol S (1998) Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J Neurovirol 4: 407–414
Studnicka-Benke A, Steiner G, Petera P, Smolen JS (1996) Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 35:1067–1074
Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22
Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M et al (2001) Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Anticancer Res 21:3053–3059
Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pita O et al (2002) Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, proinflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with proinflammatory cytokines. Clin Exp Rheumatol 20:535–538
Sjowall C, Ernerudh J, Bengtsson AA, Sturfelt G, Skogh T (2004) Reduced anti-TNF alpha autoantibody levels coincide with flare in systemic lupus erythematosus. J Autoimmun 22:315–323
Bengtsson AA, Sturfelt G, Gullstrand B, Truedsson L (2004) Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus—an additional mechanism to increased autoantigen load? Clin Exp Immunol 135:535–543
Matsuyama W, Yamamoto M, Higashimoto I, Oonakahara KI, Watanabe M, Machida K et al (2004) TNF related apoptosis inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 104:184–191
Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897
Tiefenthaler M, Bacher N, Linert H, Muhlmann O, Hofer S, Sepp N et al (2003) Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus. Lupus 12:471–478
Schultz DR, Harrington WJ Jr (2003) Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32:345–369
Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT et al (1996) A death-domain-containing receptor that mediates apoptosis. Nature 384:372–375
Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK et al (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331–8335
Pimentel-Muinos FX, Seed B (1999) Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11:783–793
Oyadomari S, Mori M (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11:381–389
Siman R, Flood DG, Thinakaran G, Neumar RW (2001) Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer’s disease-linked presenilin-1 knock-in mutation. J Biol Chem 276:44736–44743
Altznauer F, Conus S, Cavalli A, Folkers G, Simon HU (2004) Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 279:5947–5957
Huang Y, Wang KK, Vanderklish PW, Bahr BA, Kidd VJ, Lahti JM et al (2001) The calpain family and human disease. Trends Mol Med 7:355–362
Vanderklish PW, Bahr BA (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81:323–339
Kim MJ, Jo DG, Hong GS, Kim BJ, Lai M, Cho DH et al (2002) Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death. Proc Natl Acad Sci USA 99:9870–9875
Chan SL, Mattson MP (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58:167–190
Kreuter M, Langer C, Kerkhoff C, Reddanna P, Kania AL, Maddika S et al (2004) Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development. Arch Immunol Ther Exp (Warsz) 52:141–155
Acknowledgements
We gratefully thank all the patients and all the medical staffs who generously collaborated with this research. We are grateful to Ms. Oravan Verasertniyom and the staff of the Division of Allergy Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University for providing us the samples. We also thank Prof. Jisnuson Svasti for critical editing of the manuscript. This work is supported by Mahidol University Research Grant (Grant number 02011854-0005) to Yindee Kitiyanant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pitidhammabhorn, D., Kantachuvesiri, S., Totemchokchyakarn, K. et al. Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-α on this pathway. Clin Rheumatol 25, 705–714 (2006). https://doi.org/10.1007/s10067-005-0162-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0162-5